{
    "Trade/Device Name(s)": [
        "UNISCAN-DoA system",
        "UNISCAN-DoA Scanner",
        "mAMP/Opi/THC Panel Test",
        "SUDoA-01: mAMP/Opi/THC panel test",
        "USD0A-01: UNISCAN-DoA Scanner"
    ],
    "Submitter Information": "Taiwan Unison Biotech Inc.",
    "510(k) Number": "K080347",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043242"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJC",
        "DJG",
        "LDJ"
    ],
    "Summary Letter Date": "October 9, 2008",
    "Summary Letter Received Date": "September 25, 2008",
    "Submission Date": "September 23, 2008",
    "Regulation Number(s)": [
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Methamphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methamphetamine",
        "Opiates",
        "THC (Cannabinoid)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "UNISCAN-DoA Scanner"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Competitive immunoassay",
        "Colloidal gold based lateral flow"
    ],
    "Methodologies": [
        "Immunochromatographic testing"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Scanner",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for UNISCAN-DoA system, a qualitative immunochromatographic system for detection of methamphetamine, opiates, and THC in urine using a dedicated scanner and panel test.",
    "Indications for Use Summary": "Qualitative prescription assay for laboratory professional use with UNISCAN-DoA scanner to screen for methamphetamine, opiates, and cannabinoids in human urine; preliminary screening only, confirmatory testing recommended.",
    "fda_folder": "Toxicology"
}